J9395 HCPCS code: Injection, fulvestrant, 25 mg
J9395 is the HCPCS Level II code for injection, fulvestrant, 25 mg. In 2024 Medicare paid an average of $6.16 per service for J9395 across 1,108,110 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 20 per day on DME suppliers. Medicare volume fell 15% from 2022 to 2024 (1,301,177 to 1,108,110 services). In 2024, about 3,903 clinicians billed Medicare for J9395 for 7,481 beneficiaries; Florida, California, Texas accounted for 35% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2004-01-01 |
| Last action effective | 2004-01-01 |
Who bills J9395 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 3,903 |
| Medicare beneficiaries | 7,481 |
| States with claims | 44 |
| Share of services in top 3 states (Florida, California, Texas) | 35% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J9395, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 1,301,177 | 8,498 | $12.82 | $9.99 |
| 2023 | 1,080,133 | 7,312 | $10.36 | $8.06 |
| 2024 | 1,108,110 | 7,481 | $7.99 | $6.16 |
States with the most J9395 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 150,100 | $6.26 |
| California | 138,491 | $6.15 |
| Texas | 99,342 | $6.15 |
| Illinois | 55,160 | $6.19 |
| Maryland | 46,614 | $6.11 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 20 | Prescribing Information |
| outpatient hospital claims | 20 | Prescribing Information |
| practitioner claims | 20 | Prescribing Information |
What changed for J9395
- 2004-01-01: J9395 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J9395?
J9395 is the HCPCS Level II code for injection, fulvestrant, 25 mg. Short descriptor: "Injection, fulvestrant".
How much does Medicare pay for J9395?
In 2024, the average Medicare payment was $6.16 per service (average allowed $7.99).
Does Medicare cover J9395?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J9395 can be billed per day?
20 on DME suppliers; 20 on outpatient hospital claims; 20 on practitioner claims (NCCI medically unlikely edits).
Related J93 codes
- J9300 — Injection, gemtuzumab ozogamicin, 5 mg
- J9301 — Injection, obinutuzumab, 10 mg
- J9302 — Injection, ofatumumab, 10 mg
- J9303 — Injection, panitumumab, 10 mg
- J9304 — Injection, pemetrexed (pemfexy), 10 mg
- J9305 — Injection, pemetrexed, not otherwise specified, 10 mg
- J9306 — Injection, pertuzumab, 1 mg
- J9307 — Injection, pralatrexate, 1 mg
- J9308 — Injection, ramucirumab, 5 mg
- J9309 — Injection, polatuzumab vedotin-piiq, 1 mg
- J9310 — Injection, rituximab, 100 mg
- J9311 — Injection, rituximab 10 mg and hyaluronidase
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J9395
- Watch J9395 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J9395
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.